Search for Clinical Trial Results

Sponsored By

Lipodystrophy - 63 Studies Found

Status Study
Recruiting Study Name: The BROADEN Study: A Study of Volanesorsen (Formerly ISIS-APOCIIIRx) in Patients With Familial Partial Lipodystrophy
Condition: Familial Partial Lipodystrophy
Date: 2015-08-17
Interventions:
  • Drug: volanesorsen Other Name:
Recruiting Study Name: Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients
Condition: Familial Partial Lipodystrophy
Date: 2015-04-24
Interventions:
  • Drug: Obeticholic Acid Capsule
Active, not recruiting Study Name: Expanded Access Metreleptin Study
Condition: Familial Partial Lipodystrophy
Date: 2015-01-20
Interventions: Drug: Metreleptin Metreleptin open-label treatment O
Recruiting Study Name: Familial Partial Lipodystrophy Study
Condition: Lipodystrophy, Familial Partial
Date: 2016-05-19
Interventions: Other: High fat mixed meal
Recruiting Study Name: CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy
Condition:
  • Familial Partial Lipodystrophy
  • Nonalcoholic Steatohepatitis Date: 2015-01-20
    Interventions: Drug: Metreleptin MyaLept (Recombinant-methionyl Human Leptin (r-metHuLeptin) METRELEPTIN) subcutaneous
Completed Study Name: Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE
Condition: HIV-Associated Lipodystrophy Syndrome
Date: 2006-10-02
Interventions:
  • Device: Newfill 1 to 7 injecti
Completed Study Name: An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
Condition: HIV-associated Lipodystrophy Syndrome
Date: 2013-05-02
Interventions:
  • Drug: GSK1265744B (sodium salt) containing 14C-GSK1265744B

Completed Study Name: Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome
Condition: HIV-Associated Lipodystrophy Syndrome
Date: 2011-05-23
Completed Study Name: Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy
Condition: HIV-Associated Lipodystrophy Syndrome
Date: 2008-03-26
Interventions:
  • Drug: Standard continuous antiretroviral therapy
Completed Study Name: Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients
Condition: HIV-Associated Lipodystrophy Syndrome
Date: 2005-08-25
Interventions: Drug: nucleoside analogue sparing HAART regimen
Next >>>